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tumors, and malignanciesSarah N. Khan, MD; Ali R. Sepahdari, MD ⇑AbstractA wide variety of space occupying lesions may be encountered in the orbit. CT and MR imaging frequently help confirm the pres-
ence of a mass and define its extent. Characteristic imaging features may help distinguish among lesions that have overlapping
clinical presentations. This review focuses on some of the common orbital masses. Common vascular lesions that are reviewed
include: capillary (infantile) hemangioma, cavernous hemangioma (solitary encapsulated venous-lymphatic malformation), and lym-
phangioma (venous-lymphatic malformation). Benign tumors that are reviewed include: optic nerve sheath meningioma, schwan-
noma, and neurofibroma. Malignancies that are reviewed include: lymphoma, metastasis, rhabdomyosarcoma, and optic glioma.
Key imaging features that guide radiological diagnosis are discussed and illustrated.
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A wide variety of processes can produce space-occupying
lesions in and around the orbit. These include benign neo-
plasms, malignant neoplasms, vascular lesions, inflammatory
disease, congenital lesions, and infection, among other
causes. Imaging can be used to precisely localize a lesion,
to help establish a diagnosis or generate a differential diag-
nosis that guides management, to follow a known lesion for
progression, or some combination of these.
The first step in establishing a differential diagnosis is
obtaining an accurate clinical history. CT is excellent for con-
firming the presence of a mass, is well tolerated, can be rap-
idly obtained at most medical centers, and gives clues to the
specific diagnosis. Although MRI can be more difficult to per-
form, it can reveal additional key imaging features that allow
one to more confidently distinguish between similar appear-
ing lesions, and often arrive at a single most likely diagnosis.Peer review under responsibility
of Saudi Ophthalmological Society,
King Saud University
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e-mail addresses: ali.sepahdari@gmail.com, asepahdari@mednet.ucla.edu (A.Our goal is to review the most commonly encountered le-
sions to make the reader aware of their typical appearances
and presentations, with emphasis on key imaging features
that may distinguish among similar lesions.
This review focuses on the most common vascular masses,
benign neoplasms, and malignant neoplasms. Due to space
constraints, infection1–3 and inflammatory disease3–6 are not
discussed here. In addition, a number of other vascular le-
sions and neoplasms are not discussed, including orbital ve-
nous varix,3,7,8 arteriovenous malformation,3,9 cavernous
sinus thrombosis,3,10 carotid cavernous fistula,3,7,8 a variety
of benign and malignant mesenchymal tumors,3,11,12 epithe-
lial neoplasms of the lacrimal apparatus,3,7,13–15 and ocular
tumors that secondarily involve the orbit.3,7 One may also
encounter other masses that are not true neoplasms, such
as dermolipomas,3,16,17 dermoid cysts,3,18–20 and epidermoid
cysts.3,20 For discussion of these lesions, and others, we di-
rect the reader to the referenced sources.Production and hosting by Elsevier
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Capillary hemangioma (infantile hemangioma)
Clinicopathologic features
Although the term ‘‘hemangioma’’ is sometimes used to
describe certain vascular malformations, it more appropri-
ately describes a true neoplasm with vascular channels lined
by proliferating endothelial cells.21 Capillary hemangiomas
are the commonest tumors of infancy,7,22–24 typically appear-
ing as a reddish macule in the first 6 months of life. A prolif-
erative phase occurs up to 10 months, followed by a slow
involution phase for up to 10 years.21,25,26 Though typically
sporadic, they may occur as part of a genetic syndrome such
as PHACES syndrome.25Imaging findings
Contrast enhanced MRI is the preferred modality for imag-
ing hemangioma, although CT can also be considered if it is
not possible to sedate the patient for MRI. The diagnosis is
typically well-established clinically, but imaging is indicated
to assess the extent of the lesion and mass effect on adjacent
structures. With deep lesions, the clinical diagnosis may be
challenging. Capillary hemangioma typically shows: (1) lobu-
lar contour borders, (2) bright T2 signal with T2 dark septa
between lobules, (3) fine internal flow voids, (4) intense,
homogeneous enhancement, and (5) preservation of adja-
cent bone (Fig. 1). Capillary hemangioma can have an atypi-
cal appearance without all of these features. Nevertheless, if
these features are not all present, then alternative diagnoses
should be considered, including rhabdomyosarcoma. DWI
may help distinguish these lesions in challenging cases, as
rhabdomyosarcoma typically shows lower ADC and brighter
DWI signal than hemangioma.27–29 CT may demonstrate
bony orbital expansion or scalloping with rapidly growing
lesions. True bone invasion and calcifications are rarely seen.
CT and MR may both demonstrate fat deposition and
heterogeneous appearing enhancement, if imaging is
performed during the involution phase.9,23–25Differential diagnosis
Rhabdomyosarcoma, vascular malformation, infantile
fibromatosis, and infantile fibrosarcoma.Figure 1. A 7 month-old girl with capillary (infantile) hemangioma. A. Axial T2
void (arrow) that likely represents an internal high-flow vessel. Septa in betwee
shows intense, homogeneous enhancement typical of a proliferative phase
hypointense line (arrow).Key features
Bright T2 signal, lobular borders, fine internal flow voids,
extraconal location, and intense homogeneous enhancement.‘Cavernous hemangioma’ (solitary, encapsulated
venous-lymphatic malformation)
Clinicopathologic features
‘Cavernous hemangioma’ is a term that is widely used to
describe a solitary, encapsulated venous-lymphatic malfor-
mation, the most common vascular lesion of the orbit.30
The typical clinical presentation is of mostly painless propto-
sis (mean 5–6 mm), pain, lid swelling, diplopia, lump, and
recurrent obstructed vision. Middle-aged women are the
most commonly affected group, and the average duration
from symptom onset to presentation is 4 years.22 The most
frequent locations are the retrobulbar muscle cone, espe-
cially the lateral aspect of the intraconal space.31 However,
a small minority (less than 10%) of these lesions are extraco-
nal.32 Cavernous hemangiomas rarely bleed33 due to firmer
texture from the surrounding support of rich fibrous tissue.34
Orbital cavernous hemangiomas are typically solitary and uni-
lateral, though multifocal and bilateral lesions have been re-
ported.35–38Imaging appearance
Cavernous hemangioma typically appears as a well-
circumscribed intraconal mass.39–42 Although most lesions are
ovoid or round, larger lesions have lobulated margins. Larger
lesions will distort surrounding structures, as opposed to
lymphoma which molds around structures. CT shows homo-
geneous soft tissue density, and may show small calcifications
or phleboliths.39 MR shows isointense T1 signal, bright T2
signal, dark internal septations, and a dark circumferential
rim that represents a fibrous pseudocapsule (Fig. 2).22,34,43,44
MR classically demonstrates nodular enhancement on
early post-contrast images, and progressive accumulation
of contrast on delayed post-contrast images.31 The same
findings are seen with multiphase CT, though concerns
related to the increased radiation exposure of multiphase
CT make this technique relatively less desirable. Small lesions
often show early, uniform enhancement. MR angiography
and CT angiography are generally not able to identify theshows a well-defined, lobular, hyperintense mass with fine internal signal
n lobules are slightly more linear. B. Axial fat-suppressed post contrast T1
lesion. The intact bony cortex at the zygoma is well demonstrated as a
Figure 2. Cavernous hemangioma (solitary encapsulated venous-lymphatic malformation). A. Axial T2 shows an ovoid, homogeneous hyperintense mass
() that distorts the medial rectus muscle (black arrow) and the optic nerve (white arrow). B. Axial T1 with contrast, obtained immediately after contrast
injection, shows nodular enhancement. C. Para-sagittal oblique fat suppressed T1 with contrast, obtained 12 min after contrast injection, shows more
uniform contrast enhancement. This slowly progressive nodular enhancement is typical of cavernous hemangioma, though also occasionally seen in
schwannoma.
Figure 3. Lymphatic malformation (lymphangioma). Axial T2 shows a
hyperintense, trans-spatial mass involving the intra- and extra-conal
compartments. Hypointense septations (black arrows) are typical of this
lesion. Layering blood products (white arrows) are variably present, and
indicate recent intralesional bleeding.
Orbital masses: CT and MRI of common vascular lesions, benign 375feeding vessels of a cavernous hemangioma, likely due to
their small caliber.
Differential diagnosis
Venous varix, schwannoma, optic nerve sheath meningi-
oma, and lymphoma.
Key imaging features
Intraconal location; very bright T2 signal with hypointense
pseudocapsule; and an early nodular enhancement with pro-
gressive accumulation of contrast on later phase images.
Lymphangioma (venous lymphatic malformation)
Clinicopathologic features
‘Lymphangiomas’ are benign vascular malformations (ve-
nous lymphatic malformations), commonly affecting children
and rarely involving the orbit. They are unencapsulated and
composed of fibrous material including endothelial lacunae
filled with blood or serious fluid.45 Lymphangiomas tend to
enlarge suddenly due to intralesional bleeding, but may also
enlarge with upper respiratory infection.46 Symptoms in-
clude: swelling, intraorbital hemorrhage, ocular proptosis,
blepharoptosis and cellulitis. Ocular complications include:
astigmatism, corneal exposure, hyperopia secondary to pres-
sure on posterior globe, strabismus, glaucoma and compres-
sive optic neuropathy.47–49
Imaging findings
Despite belonging to the same pathological category as
‘cavernous hemangioma’ (i.e. low flow vascular malformation
without endothelial proliferation), lymphangioma has a differ-
ent appearance and growth pattern. In keeping with their
unencapsulated nature, lymphangiomas exhibit an infiltra-
tive, trans-spatial growth pattern, often involving both the
intraconal and extraconal compartments and pre- and
post-septal compartments, violating fascial planes. Both
microcysts and macrocysts may be identified.50 CT may dem-
onstrate phleboliths in the venous component of a lesion,
and may demonstrate bony abnormalities.46 Venous or solidcomponents of the tumor are hyperdense compared to brain
tissue on unenhanced CT scans.50–52
MR is accurate for delineating the anatomic location and
vascular components, and fluid filled levels or menisci can
be seen.46 The mass is usually isointense to slightly hyperin-
tense relative to normal brain tissue on T1 weighted imaging
and very hyperintense relative to the brain on T2 weighted
imaging46, with internal septations (Fig. 3). T1 and T2 signal
intensity vary depending on the presence and age of internal
blood products. The venous component of a lesion will typi-
cally enhance, whereas the lymphatic component will only
show fine enhancement of septations. No flow voids or en-
larged feeder vessels are usually found, in keeping with the
low flow nature of lymphangioma and differentiating it from
high flow lesions, including high-flow vascular malformations
and true neoplasms such as capillary hemangioma.50,53,54
Figure 4. Optic nerve sheath meningioma. A. Axial T2 shows a homogeneous, hypointense mass () that mildly distorts the globe (arrow). B. Axial fat
suppressed T1 with contrast shows homogeneous enhancement with a well-defined margin (blue arrow), and encasement of the optic nerve (white
arrow). Globe distortion helps distinguish this lesion from lymphoma, as does the clinical history of slowly progressive, painless vision loss.
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Cavernous hemangioma, capillary hemangioma, dermoid,
and rhabdomyosarcoma.
Key imaging features
Trans-spatial, markedly T2 bright non-enhancing mass
with internal septations, with or without layering blood prod-
ucts and solidly enhancing components.
Benign neoplasms
Optic nerve sheath meningioma
Clinicopathologic features
The typical clinical presentation of optic nerve sheath
meningioma is painless, gradual vision loss and proptosis in
a woman between ages 30 and 50. Optic nerve sheath
meningioma is typically unilateral but can be bilateral, partic-
ularly in the setting of type II neurofibromatosis. Primary
meningioma arises from capillary cells of the arachnoid
around the intraorbital or intracanalicular portions of the op-
tic nerve. Secondary meningioma arises intracranially from
the sphenoid ridge, tuberculum sellae, or olfactory groove
and invades the optic canal and orbit by extension between
the dura and arachnoid of the optic nerve.55,56 Visual distur-
bance in the affected eye is common. While some patients
only suffer transient visual loss lasting a few seconds, others
experience visual loss in a particular field of gaze.57,58 Optic
neuropathy, proptosis and strabismus occur later.
Imaging findings
The key imaging finding of optic nerve sheath meningi-
oma is a homogeneously enhancing mass that surrounds
the optic nerve. CT may show calcification. MRI typically
shows homogeneous, intermediate T1 and T2 signals. The
optic nerve may be in the center of the lesion, or may be
eccentrically positioned. In some cases, the optic nerve will
show abnormal T2 hyperintense signal, which is presumably
related to chronic venous insufficiency.
Optic nerve sheath meningioma may produce an expan-
sile mass (Fig. 4). Alternatively, it may only form a thin sheet
around the optic nerve, termed ‘‘en plaque meningioma’’,producing the classically described ‘tram track’ sign.59 In
these cases, fat-suppressed post-contrast T1-weighted
images in the coronal plane are essential in making the diag-
nosis (Fig. 5). Any part of the nerve may be involved, and
radiologic diagnosis can be challenging when only the intra-
canalicular portion of the nerve is affected. Fat suppression is
helpful in these cases, but can also be degraded by blooming
artifact around a well-pneumatized sphenoid sinus. For this
reason, coronal post-contrast images without fat suppression
should also be considered.
Optic nerve sheath meningioma is distinguished from op-
tic glioma by the fact that the optic glioma expands the optic
nerve. Orbital lymphoma can sometimes surround the optic
nerve and simulate optic nerve sheath meningioma by imag-
ing (Fig. 6). In such cases, lymphoma’s tendency to mold
around structures helps differentiate it from meningioma,
which tends to distort structures. Lymphoma also typically
shows less intense enhancement than meningioma. Meningi-
oma frequently shows calcification on CT, whereas untreated
lymphoma almost never calcifies. Perineuritic inflammatory
disease can produce a similar appearance to en plaque
meningioma, but is clinically distinguished by the presence
of pain. Demyelinating optic neuritis is distinguished from
en plaque meningioma by its typical homogeneous enhance-
ment of the substance of the nerve, as opposed to the target-
like enhancement of meningioma.
Differential diagnosis
Sarcoidosis, pseudotumors, lymphoma, and optic neuritis.
Key imaging features
Mass surrounding and constricting the optic nerve; calcifi-
cation on CT; extension of tumor into the optic canal; ‘‘tram
track’’ or ‘‘target’’ like enhancement.
Nerve sheath tumors
Clinicopathologic features
Nerve sheath tumors can be divided into schwannomas
and neurofibromas, which are less common and typically
associated with NF-1. Schwannomas constitute 1% of orbital
tumors, typically occurring in young and middle-aged
Figure 5. En plaque optic nerve sheath meningioma. Coronal fat
suppressed T1 with contrast shows an enhancing mass (blue arrow)
surrounding and constricting the optic nerve (white arrow). Fat sup-
pressed post contrast coronal images are essential in identifying menin-
giomas with this growth pattern.
Figure 7. Schwannoma. Axial CT with contrast shows a hypodense, well-
defined, extraconal mass with only weak enhancement. This appearance
is nonspecific, and is often seen with schwannoma in addition to other
benign and malignant masses.
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V1,60 and produce symptoms related to local mass effect.
Schwannomas are associated with NF-1 in 2–18% of pa-
tients.61 Neurofibromas are more strongly associated with
NF-1, and also produce symptoms related to mass effect.Figure 8. Plexiform neurofibroma. Axial fat suppressed T2 shows a
hyperintense mass in the left orbit, with extension through the superior
orbital fissure (arrow) into the parasellar region.Imaging findings
Schwannoma appears as a smooth, ovoid, orbital retrobul-
bar mass, found in the intra- or extra-conal space with the
long axis in the anterior–posterior direction (Fig. 7).39,62 CT
shows isodensity or hypodensity compared to gray matter.
MR shows isointense T1 signal, and T2 hyperintensity. Although
some schwannomas may be cystic and non-enhancing,63
most schwannomas enhance with contrast. Although
schwannoma enhancement is typically more homogeneous
than cavernous hemangioma, in some cases schwannoma
can show the same type of early nodular enhancement with
progressive fill-in that is commonly seen with cavernous hem-
angioma. The MR and CT appearance of schwannoma can
overlap with optic nerve sheath meningioma. In challenging
cases, one should look carefully for extension into the supe-
rior orbital fissure, which would favor schwannoma, or for
extension into the optic canal, which would favor meningi-
oma. Neurofibromas often have a similar appearance to sch-
wannomas, though plexiform neurofibromas typically show aFigure 6. Lymphoma. A. Coronal fat suppressed T2 shows a homogeneous, s
Although the mass is mostly well-defined, there is a slightly ill-defined lateral m
globe without globe distortion (arrow). Although optic nerve encasement is typ
are features that suggest lymphoma. Lymphoma also commonly shows slightly
compared to Fig. 4.more infiltrative growth pattern (Fig. 8), and are frequently
associated with other stigmata of NF-1.Differential diagnosis
Cavernous hemangioma, meningioma, and lymphoma.Key imaging features
Smooth, homogeneous spherical mass. Extension into
superior orbital fissure. Enhancement is typically moreomewhat hypointense mass that surrounds the optic nerve (white arrow).
argin (yellow arrow). B. Axial fat suppressed T1 shows molding around the
ical of meningioma, molding around the globe and poor margin definition
less intense enhancement than meningioma, as demonstrated in this case
Figure 9. Lymphoma (multiple cases). A. Axial fat suppressed T1 with contrast shows ill-defined intraconal enhancement (arrow), representing infiltrative
tumor. B. Parasagittal oblique T1 with contrast in a different patient shows an enhancing mass expanding the superior rectus muscle (arrow). C. Axial T2
in a third patient shows diffuse expansion of the right lacrimal gland, with slightly lobular contour. The mass respects the cortex of the zygoma (white
arrow) and molds around the globe without distorting it (blue arrow). D. Axial DWI (same patient as ‘C’) shows very bright signal in both lacrimal glands
(yellow arrows), reflecting involvement by hypercellular tumor. Left lacrimal gland disease is better detected with DWI than with conventional images,
due to the relatively normal size of the gland and homogeneous appearance.
Figure 10. Breast cancer metastasis. A. Axial T2 shows a hypointense retrobulbar mass (arrow) that produces slight posterior tenting of the globe. B.
Axial fat suppressed T1 with contrast shows ill-defined enhancement. Enophthalmos and a T2 dark mass are highly suggestive of breast cancer
metastasis.
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ular than cavernous hemangioma.Malignant neoplasms
Orbital lymphoid tumors (including malignant
lymphoma)
Clinicopathologic features
Reactive lymphoid lesions overlap histologically with
malignant lymphoma, and are sometimes grouped as ‘orbital
lymphoid lesions’.64 The typical presentation is low-grade
proptosis with minimal pain.1 Lymphoid masses comprise
10–15% of all orbital tumors65 and up to 55% of malignantorbital masses.66 Malignant lymphoma of the orbit is typically
B cell lymphoma of a non-Hodgkin type, arising from muco-
sa-associated lymphoid tissue of ocular adnexa (MALTOM-
A).67 Systemic lymphoma may involve the orbit in 1.5–5% of
patients.68,69 Up to 75% of patients with orbital lymphoma
may later develop systemic disease.70 Suspicion of malignant
lymphoma is increased in the presence of systemic disease,
lacrimal duct or gland disease, and bilateral disease.71
Image appearance
Lymphoid tumors typically appear as homogeneous, lobu-
lated masses on CT and MRI. They mold around normal struc-
tures without deforming them, and typically do not erode
adjacent bone. They may be well defined, or infiltrative in
appearance. CT shows density similar to skeletal muscle.
Figure 11. Carcinoid tumor metastasis. Parasagittal oblique fat sup-
pressed T1 with contrast shows a peripherally enhancing mass centered in
the distal portion of the inferior rectus muscle (arrow).
Orbital masses: CT and MRI of common vascular lesions, benign 379MRI demonstrates homogenous, intermediate T1 and T2 sig-
nals, and homogeneous contrast enhancement.64,72,73
Lymphomas most commonly involve the superolateral as-
pect of the orbit,72 and bilateral disease is common.1 When
multiple sites of disease are present, the intraconal space is
most affected (85%). Lymphoma can involve virtually any part
of the orbit, including the lacrimal gland, extraocular mus-
cles, lacrimal sac, periorbital fat, and retrobulbar fat (Fig. 9).
Lymphoma can be very difficult to distinguish from orbital
inflammatory disease (‘‘pseudotumor’’). However, diffusion-
weighted imaging (DWI) is an MRI technique that has recently
been proven effective in distinguishing these entities. Lym-
phoma typically shows brighter DWI signal and lower appar-
ent diffusion coefficient (ADC) than normal orbital structures,
due to its hypercellular nature. Inflammatory lesions, on the
other hand, tend to show intermediate DWI and ADC signals,
similar to normal lacrimal gland.27 Very low T2 signal (darker
than normal white matter) should also suggest an inflamma-
tory lesion.5 DWI is also helpful for identifying lacrimal gland
lymphoma.Differential diagnosis
Orbital inflammatory syndrome, optic nerve sheath menin-
gioma, and orbital metastasis.Key imaging features (lymphoma)
Homogeneous intermediate T2 signal, lobulated margins
with molding around normal structures, homogeneous
enhancement, brighter DWI signal and lower ADC than sur-
rounding normal orbital tissues.Figure 12. Colonic adenocarcinoma metastasis. Axial T1 with contrast
shows a necrotic mass centered in the right sphenoid triangle (), with
enhancing tumor and surrounding inflammation along the margins
extending into the middle cranial fossa and extraconal orbit.Metastatic tumors of the orbit
Clinicopathologic features
In adults orbital metastases usually arise from carcinoma-
tous origin, in children sarcomatous or neural embryonal tu-
mors are more common.74 The spread of tumor to the orbit
and ocular adnexa is usually due to hematogenous spread
of primary cancer, and is associated with a poor prognosis.
Primary metastatic orbital tumors are estimated to account
for 1–13% of all orbital tumors, and in cancer patients are
prevalent from 2% to 4.7%.75 Improved cancer therapy, im-
proved diagnostic imaging and increased awareness in med-
ical literature have allowed for better diagnosis of these
tumors.Metastatic lesions are found more in the anterior orbit
than the posterior orbit.76 The most frequent metastases to
the orbit are from: breast, lung, prostate, melanoma, carci-
noid, GI, renal cell, neuroblastomas and rhabdomyosarco-
mas. Rapidly progressive symptoms occur including:
diplopia, proptosis, decreased vision, pain, ptosis, and palpa-
ble mass.75
Imaging findings
CT is usually performed for orbital imaging, although MR
has superior soft tissue contrast. Tumor pattern can vary from
diffusely infiltrative with obscured anatomical landmarks to a
focal well-defined mass. Orbital metastases from breast can-
cer are often diffuse and irregular growing along the rectus
muscles and fascial planes.76 Scirrhous (fibrotic) breast can-
cers are unique in their ability to produce enophthalmos
and ophthalmoplegia. In these cases, the metastatic lesion
is typically very T2 dark, reflecting its fibrotic nature
(Fig. 10). Metastases from carcinoid (Fig. 11), renal cell carci-
noma and melanoma tend to be circumscribed. All orbital
metastases show some degree of MR enhancement.77 Metas-
tases may involve any structure in the orbit, including the
intraconal or extraconal space, globe, extraocular muscles
and bone (Fig. 12).
Differential diagnosis
Lymphoma, infection, dysthyroid orbitopathy, orbital
inflammatory disease, carotid cavernous fistula, and cavern-
ous sinus thrombosis.
Key imaging findings
Imaging findings vary widely. Globe retraction is highly
suspicious for scirrhous breast cancer metastasis.
Rhabdomyosarcoma
Clinicopathologic features
This is the most common soft tissue malignancy of child-
hood and most common primary orbital malignancy.78,79
There is a bimodal distribution of affected ages, commonly
occurring between 2 and 5 years80 but is reported in all age
groups.81 The embryonal subtype occurs in childhood (mean
age 8 years; male to female ratio 5:3); the pleomorphic sub-
type occurs in adults; the alveolar subtype occurs in young
children and adults and is associated with a poor prognosis.79
Primary rhabdomyosarcoma can occur from the conjunc-
tiva, iris, ciliary body, or extension of primary orbital rhabdo-
myosarcoma.82 Secondary orbital rhabdomyosarcoma occurs
Figure 13. A 26 year-old woman with rhabdomyosarcoma. CT shows an
aggressive mass that deforms the globe and grossly destroys bone
(arrow), invading the ethmoid sinus through the lamina papyracea.
380 S.N. Khan, A.R. Sepahdarifrom direct extension to orbits from the paranasal sinus,
pterygopalatine fossa, infratemporal fossa or nasopharynx.
Orbital metastases can also occur from other head and neck
rhabdomyosarcomas and carries a poor prognosis. The orbi-
tal location varies: extraconal (37%), intraconal (17%), both
(47%). The upper outer quadrant is involved in 67%. Present-
ing complaints include: unilateral proptosis (80–100%), globe
displacement (80%), ptosis (30–50%), conjunctival and eyelid
swelling (60%), palpable mass (25%), and pain (10%).83,84Imaging findings
CT shows moderately well defined to ill-defined margins,
irregular shape, and mild-moderate contrast enhancement.
Adjacent bony destruction occurs in 40% (Fig. 13). Globe dis-
tortion85 and extension to the paranasal sinuses82,86 may also
be seen. Regional lymph nodes are involved later in the dis-
ease course. Calcification is rare in untreated tumors.
MR typically shows bright T2 signal, distinguishing rhab-
domyosarcoma from other tumors such as chloroma (granu-
locytic sarcoma), lymphoma and metastatic neuroblastoma
(Fig. 14). MR may also better delineate the true extent of dis-
ease if surgical resection is planned.87 On occasion, a pyo-
genic abscess may have a subacute presentation that
mimics a necrotic rhabdomyosarcoma clinically and by imag-
ing.88 In such cases, MRI with DWI is critical in distinguishingFigure 14. A 3 year-old boy with embryonal rhabdomyosarcoma. A. Axial T2
extraconal soft tissues, without destruction of the bone or distortion of adja
homogeneous enhancement. This mass has certain features that are common t
first year of life, absence of flow voids, and absence of discrete lobules with T2these entities, through demonstration of restricted diffusion
of pus in an abscess cavity,89 as opposed to elevated diffu-
sion in the necrotic portion of a tumor.90
Differential diagnosis
Leukemic metastatic deposits; Langerhans cell histiocyto-
sis; aggressive fibromatosis; ruptured dermoid cyst; subperi-
osteal hematoma; plexiform neurofibromatosis, capillary
hemangioma.
Key imaging features




Optic nerve glioma comprises 1.5–3.0% of orbital tumors,
0.6–7.0% of all intracranial tumors, 1.7–7.0% of gliomas, and
2–5% of gliomas in the pediatric age group.91,92 The peak
incidence is in 2–8 year old but can occur at any age and
has been reported at up to 79 years of age.93,94 Females
are more affected than males. There is a high association
(12–37%) with type I neurofibromatosis type 195, which fre-
quently shows bilateral lesions. Notably, optic gliomas asso-
ciated with NF-1 typically have more indolent behavior than
isolated optic nerve gliomas. Symptoms include: proptosis,
decreased visual acuity,96 nystagmus, strabismus, central/
paracentral field defects, dyschromatopsia, and afferent
pupillary defect.92 Disk edema and atrophy may be evident
by 8 weeks. The tumors are slow growing with periods of
growth and dormancy,97,98 some may regress com-
pletely.99,100 In an analysis of affected orbital locations, 48%
involved the orbital optic nerve, 24% the orbital and intracra-
nial optic nerve, 10% intracranial optic nerve and chiasm, and
just chiasm in up to 5%.101 Surgery is typically reserved for
cases where there is significant mass effect.
Imaging findings
MR is optimal for imaging optic nerve glioma.102 The clas-
sic finding of optic nerve glioma is sharply circumscribed fusi-
form thickening and tortuosity of the optic nerve. Optic
gliomas are typically T2 hyperintense, and usually show someshows a well-defined, hyperintense mass involving the retrobulbar and
cent structures. B. Axial fat-suppressed T1 with contrast shows intense,
o capillary hemangioma. However, continued growth of the mass after the
hypointense septations, are features that suggest an alternative diagnosis.
Figure 15. Optic glioma. A. Axial fat-suppressed T1 with contrast shows a solidly enhancing dumbbell-shaped mass extending through the right optic
canal (arrow). B. Coronal fat-suppressed T1 with contrast shows diffuse enhancement of the substance of the right optic nerve (arrow), a finding that
confirms optic glioma rather than optic nerve sheath meningioma. Meningioma forms an enhancing mass that surrounds and constricts the optic nerve.
Orbital masses: CT and MRI of common vascular lesions, benign 381enhancement, though a wide range of signal intensities and
enhancement patterns may be encountered.103 Diffuse
involvement of the substance of the nerve differentiates optic
nerve glioma from optic nerve sheath meningioma, which
surrounds the optic nerve. Any part of the optic nerve may
be involved, from the globe to the optic chiasm. Peripheral
enhancement of chiasmatic gliomas represents extraneural
growth of tumor into the subarachnoid space, mixed with gli-
omatous tissue and non enhancing central tumor. Optic
nerve gliomas that extend to the chiasm through the optic
canal form a dumbbell shape (Fig. 15).
Differential diagnosis
Optic nerve sheath meningioma and medulloepithelioma.
Key imaging features
Diffuse enlargement of the substance of the optic nerve,
with thickening and tortuosity.
Conclusion
A wide variety of lesions may be encountered in the orbit.
Knowledge of the most common lesions, their typical clinical
presentation, typical imaging appearance, and key features
that distinguish from similar lesions should allow the reader
to make the best use of imaging.
References
1. Kapur R, Sepahdari AR, Mafee MF, et al. MR imaging of orbital
inflammatory syndrome, orbital cellulitis, and orbital lymphoid
lesions: the role of diffusion-weighted imaging. AJNR Am J
Neuroradiol 2009;30(1):64–70.
2. Uehara F, Ohba N. Diagnostic imaging in patients with orbital
cellulitis and inflammatory pseudotumor. Int Ophthalmol Clin
2002;42(1):133–42.
3. Som P, Curtin H. Head and neck imaging; 2011.
4. Yuen SJ, Rubin PA. Idiopathic orbital inflammation: distribution,
clinical features, and treatment outcome. Archiv Ophthalmol
2003;121(4):491–9.
5. Cytryn AS, Putterman AM, Schneck GL, Beckman E, Valvassori GE.
Predictability of magnetic resonance imaging in differentiation of
orbital lymphoma from orbital inflammatory syndrome. Ophthalmic
Plast Reconstr Surg 1997;13(2):129–34.
6. Yan J, Wu Z, Li Y. The differentiation of idiopathic inflammatory
pseudotumor from lymphoid tumors of orbit: analysis of 319 cases.
Orbit 2004;23(4):245–54.
7. Shields JA, Shields CL, Scartozzi R. Survey of 1264 patients with
orbital tumors and simulating lesions: The 2002 Montgomery
Lecture. Part 1. Ophthalmology 2004;111(5):997–1008.8. Smoker WR, Gentry LR, Yee NK, Reede DL, Nerad JA. Vascular
lesions of the orbit: more than meets the eye. Radiograph: A Rev
Publ Radiol Soc North America, Inc. 2008;28(1):185–204 quiz 325.
9. Bilaniuk LT. Vascular lesions of the orbit in children. Neuroimag Clin
North America 2005;15(1):107–20.
10. Goawalla A, Mansell N, Pearson A. Septic cavernous sinus
thrombosis with bilateral secondary orbital infection. Orbit
2007;26(2):113–6.
11. Patel R, Mukherjee B. Mesenchymal chondrosarcoma of the orbit.
Orbit 2012;31(2):126–8.
12. Yang BT, Wang YZ, Wang XY, Wang ZC. Mesenchymal
chondrosarcoma of the orbit: CT and MRI findings. Clin Radiol
2012;67(4):346–51.
13. Kousoubris PD, Rosman DA. Radiologic evaluation of lacrimal and
orbital disease. Otolaryng Clin North America 2006;39(5):865–93 vi.
14. Mafee MF, Edward DP, Koeller KK, Dorodi S. Lacrimal gland tumors
and simulating lesions. Clinicopathologic and MR imaging features.
Radiol Clin North America 1999;37(1):219–39 xii.
15. Vajaranant TS, Mafee MF, Kapur R, Rapoport M, Edward DP.
Medulloepithelioma of the ciliary body and optic nerve:
clinicopathologic, CT, and MR imaging features. Neuroimag Clin
North America 2005;15(1):69–83.
16. Eijpe AA, Koornneef L, Bras J, Verbeeten Jr B, Peeters FL,
Zonneveld FW. Dermolipoma: characteristic CT appearance. Doc
ophthalmol. Adv Ophthalmol 1990;74(4):321–8.
17. Kim E, Kim HJ, Kim YD, Woo KI, Lee H, Kim ST. Subconjunctival fat
prolapse and dermolipoma of the orbit: differentiation on CT and
MR imaging. AJNR Am J Neuroradiol 2011;32(3):465–7.
18. Pham NS, Dublin AB, Strong EB. Dermoid cyst of the orbit and
frontal sinus: a case report. Skull Base: Off J North American Skull
Base Soc.....et al. 2010;20(4):275–8.
19. Yeola M, Joharapurkar SR, Bhole AM, Chawla M, Chopra S, Paliwal
A. Orbital floor dermoid: an unusual presentation. Indian J
Ophthalmol 2009;57(1):51–2.
20. Jung WS, Ahn KJ, Park MR, et al. The radiological spectrum of
orbital pathologies that involve the lacrimal gland and the lacrimal
fossa. Korean J Radiol: Off J Korean Radiol Soc 2007;8(4):336–42.
21. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations
in infants and children: a classification based on endothelial
characteristics. Plast Reconstr Surg 1982;69(3):412–22.
22. Bilaniuk LT. Orbital vascular lesions. Role of imaging. Radiol Clin
North America 1999;37(1):169–83 xi.
23. Haik BG, Karcioglu ZA, Gordon RA, Pechous BP. Capillary
hemangioma (infantile periocular hemangioma). Surv Ophthalmol
1994;38(5):399–426.
24. Dubois J, Garel L. Imaging and therapeutic approach of
hemangiomas and vascular malformations in the pediatric age
group. Pediat Radiol 1999;29(12):879–93.
25. Burrows PE, Laor T, Paltiel H, Robertson RL. Diagnostic imaging in
the evaluation of vascular birthmarks. Dermatol Clin
1998;16(3):455–88.
26. Haik BG, Jakobiec FA, Ellsworth RM, Jones IS. Capillary
hemangioma of the lids and orbit: an analysis of the clinical
features and therapeutic results in 101 cases. Ophthalmology
1979;86(5):760–92.
27. Sepahdari AR, Aakalu VK, Setabutr P, Shiehmorteza M, Naheedy JH,
Mafee MF. Indeterminate orbital masses: restricted diffusion at MR
382 S.N. Khan, A.R. Sepahdariimaging with echo-planar diffusion-weighted imaging predicts
malignancy. Radiology 2010;256(2):554–64.
28. Politi LS, Forghani R, Godi C, et al. Ocular adnexal lymphoma:
diffusion-weighted mr imaging for differential diagnosis and
therapeutic monitoring. Radiology 2010;256(2):565–74.
29. Razek AA, Elkhamary S, Mousa A. Differentiation between benign
and malignant orbital tumors at 3-T diffusion MR-imaging.
Neuroradiology 2011;53(7):517–22.
30. Shields JA, Bakewell B, Augsburger JJ, Flanagan JC. Classification
and incidence of space-occupying lesions of the orbit. A survey of
645 biopsies. Archiv Ophthalmol 1984;102(11):1606–11.
31. Ansari SA, Mafee MF. Orbital cavernous hemangioma: role of
imaging. Neuroimag Clin North America 2005;15(1):137–58.
32. Harris GJ, Jakobiec FA. Cavernous hemangioma of the orbit. J
Neurosurg 1979;51(2):219–28.
33. Zenobii M, Galzio RJ, Lucantoni D, Caffagni E, Magliani V.
Spontaneous intraorbital hemorrhage caused by cavernous
angioma of the orbit. J Neurosurg Sci 1984;28(1):37–40.
34. Thorn-Kany M, Arrue P, Delisle MB, Lacroix F, Lagarrigue J, Manelfe
C. Cavernous hemangiomas of the orbit: MR imaging. J
Neuroradiol. J Neuroradiol 1999;26(2):79–86.
35. Ruchman MC, Flanagan J. Cavernous hemangiomas of the orbit.
Ophthalmology 1983;90(11):1328–36.
36. Wolin MJ, Holds JB, Anderson RL, Mamalis N. Multiple orbital
tumors were cavernous hemangiomas. Ann Ophthalmol
1990;22(11):426–8.
37. Sullivan TJ, Aylward GW, Wright JE, Moseley IF, Garner A. Bilateral
multiple cavernous haemangiomas of the orbit. The Brit J
Ophthalmol 1992;76(10):627–9.
38. Shields JA, Hogan RN, Shields CL, Eagle Jr RC, Kennedy RH, Singh
AD. Bilateral cavernous haemangiomas of the orbit. The Brit J
Ophthalmol 2000;84(8):928.
39. Mafee MF, Putterman A, Valvassori GE, Campos M, Capek V.
Orbital space-occupying lesions: role of computed tomography and
magnetic resonance imaging. An analysis of 145 cases. Radiol Clin
North America 1987;25(3):529–59.
40. Gyldensted C, Lester J, Fledelius H. Computed tomography of
orbital lesions. A radiological study of 144 cases. Neuroradiology
1977;13(3):141–50.
41. Savoiardo M, Strada L, Passerini A. Cavernous hemangiomas of the
orbit: value of CT, angiography, and phlebography. AJNR Am J
Neuroradiol 1983;4(3):741–4.
42. Forbes GS, Sheedy 2nd PF, Waller RR. Orbital tumors evaluated by
computed tomography. Radiology 1980;136(1):101–11.
43. Bilaniuk LT, Rapoport RJ. Magnetic resonance imaging of the orbit.
Top Magn Reson Imag: TMRI 1994;6(3):167–81.
44. Fries PD, Char DH, Norman D. MR imaging of orbital cavernous
hemangioma. J Comput Assist Tomogr 1987;11(3):418–21.
45. Lemke AJ, Kazi I, Felix R. Magnetic resonance imaging of orbital
tumors. Eur Radiol 2006;16(10):2207–19.
46. Chung EM, Smirniotopoulos JG, Specht CS, Schroeder JW, Cube R.
From the archives of the AFIP: Pediatric orbit tumors and tumorlike
lesions: nonosseous lesions of the extraocular orbit. Radiograph: A
Rev Publ Radiol Soc North America, Inc. 2007;27(6):1777–99.
47. Greene AK, Burrows PE, Smith L, Mulliken JB. Periorbital lymphatic
malformation: clinical course and management in 42 patients. Plast
Reconstr Surg 2005;115(1):22–30.
48. Coll GE, Goldberg RA, Krauss H, Bateman BJ. Concomitant
lymphangioma and arteriovenous malformation of the orbit. Am J
Ophthalmol 1991;112(2):200–5.
49. Eiferman RA, Gushard RH. Chocolate cysts of the orbit. Ann
Ophthalmol 1986;18(4):156–7.
50. Bisdorff A, Mulliken JB, Carrico J, Robertson RL, Burrows PE.
Intracranial vascular anomalies in patients with periorbital lymphatic
and lymphaticovenous malformations. AJNR Am J Neuroradiol
2007;28(2):335–41.
51. Baker LL, Dillon WP, Hieshima GB, Dowd CF, Frieden IJ.
Hemangiomas and vascular malformations of the head and
neck: MR characterization. AJNR Am J Neuroradiol
1993;14(2):307–14.
52. Wright JE, Sullivan TJ, Garner A, Wulc AE, Moseley IF. Orbital
venous anomalies. Ophthalmology 1997;104(6):905–13.
53. Forbes G. Vascular lesions in the orbit. Neuroimag Clin North
America 1996;6(1):113–22 vii.
54. Castillo M, Mukherji SK, Wagle NS. Imaging of the pediatric orbit.
Neuroimag Clin North America 2000;10(1):95–116 viii.55. Miller NR. Primary tumours of the optic nerve and its sheath. Eye
(Lond) 2004;18(11):1026–37.
56. Dutton JJ. Optic nerve gliomas and meningiomas. Neurol Clin
1991;9(1):163–77.
57. Bradbury PG, Levy IS, McDonald WI. Transient uniocular visual loss
on deviation of the eye in association with intraorbital tumours. J
Neurol, Neurosurg, Psychiatr 1987;50(5):615–9.
58. Oohira A, Kubo R. Ocular blood flow defect in gaze-evoked
amaurosis. Nippon Ganka Gakkai Zasshi 1999;103(1):56–60.
59. Mafee MF, Goodwin J, Dorodi S. Optic nerve sheath meningiomas.
Role of MR imaging. Radiol Clin North America 1999;37(1):37–58 ix.
60. Albert D. Principles and practice of ophthalmology. 2nd
ed. Philadelphia: WB Saunders; 2000.
61. Gunduz K, Shields CL, Gunalp I, Erden E, Shields JA. Orbital
schwannoma: correlation of magnetic resonance imaging and
pathologic findings. Graefe’s Archiv Clin Exp Ophthalmol =
Albrecht von Graefes Archiv klin exp Ophthalmol
2003;241(7):593–7.
62. Dervin JE, Beaconsfield M, Wright JE, Moseley IF. CT findings in
orbital tumours of nerve sheath origin. Clin Radiol 1989;40(5):475–9.
63. Lam DS, Ng JS, To KF, Abdulah V, Liew CT, Tso MO. Cystic
schwannoma of the orbit. Eye (Lond) 1997;11(Pt 6):798–800.
64. Westacott S, Garner A, Moseley IF, Wright JE. Orbital lymphoma
versus reactive lymphoid hyperplasia: an analysis of the use of
computed tomography in differential diagnosis. The Brit J
Ophthalmol 1991;75(12):722–5.
65. Peyster RG, Shapiro MD, Haik BG. Orbital metastasis: role of
magnetic resonance imaging and computed tomography. Radiol
Clin North America 1987;25(3):647–62.
66. Margo CE, Mulla ZD. Malignant tumors of the orbit. Analysis of the
florida cancer registry. Ophthalmology 1998;105(1):185–90.
67. Valvassori GE, Sabnis SS, Mafee RF, Brown MS, Putterman A.
Imaging of orbital lymphoproliferative disorders. Radiol Clin North
America 1999;37(1):135–50 x–xi.
68. Rosenberg SA, Diamond HD, Jaslowitz B, Craver LF.
Lymphosarcoma: a review of 1269 cases. Medicine 1961;40:31–84.
69. Bairey O, Kremer I, Rakowsky E, Hadar H, Shaklai M. Orbital and
adnexal involvement in systemic non-Hodgkin’s lymphoma. Cancer
1994;73(9):2395–9.
70. Flanders AE, Espinosa GA, Markiewicz DA, Howell DD. Orbital
lymphoma. Role of CT and MRI. Radiol Clin North America
1987;25(3):601–13.
71. Akansel G, Hendrix L, Erickson BA, et al. MRI patterns in orbital
malignant lymphoma and atypical lymphocytic infiltrates. Eur J
Radiol 2005;53(2):175–81.
72. Hosten N, Schorner W, Zwicker C, et al. Lymphocytic infiltrations of
the orbit in MRT and CT. Lymphoma, pseudolymphoma and
inflammatory pseudotumor. RoFo: Fortschritte auf dem Gebiete
der Rontgenstrahlen und der Nuklearmedizin 1991;155(5):445–51.
73. Issing PR, Ruh S, Kloss A, Kuske M, Lenarz T. Diagnosis and therapy
of lymphoid tumors of the orbits. Hno 1997;45(7):545–50.
74. Garrity JA. Metastatic carcinomasHenderson’s orbital tumors. New
York: Raven Press; 2007. p. 313–26.
75. Ahmad SM, Esmaeli B. Metastatic tumors of the orbit and ocular
adnexa. Curr Opin Ophthalmol 2007;18(5):405–13.
76. Shields JA, Shields CL, Brotman HK, Carvalho C, Perez N, Eagle Jr
RC. Cancer metastatic to the orbit: the 2000 Robert M. Curts
lecture. Ophthal Plast Reconstr Surg 2001;17(5):346–54.
77. DePotter PDC, Shields JA. MRI of the eye and orbit. Philadelphia: JB
Lippincott Co.; 1995, pp. 237–43.
78. MacArthur CJ, McGill TJ, Healy GB. Pediatric head and neck
rhabdomyosarcoma. Clin Pediatr 1992;31(2):66–70.
79. Volpe NJ, Jakobiec FA. Pediatric orbital tumors. Int Ophthalmol Clin
1992;32(1):201–21.
80. Walton RC, Ellis Jr GS, Haik BG. Rhabdomyosarcoma presumed
metastatic to the orbit. Ophthalmology 1996;103(9):1512–6.
81. Shields JA, Shields CL. Rhabdomyosarcoma of the orbit. Int
Ophthalmol Clin 1993;33(3):203–10.
82. Shields JA, Shields CL. Rhabdomyosarcoma: review for the
ophthalmologist. Surv Ophthalmol 2003;48(1):39–57.
83. Jones IS, Reese AB, Kraut J. Orbital rhabdomyosarcoma. An analysis
of 62 cases. Am J Ophthalmol 1966;61(4):721–36.
84. Jones IS, Reese AB, Krout J. Orbital rhabdomyosarcoma: an analysis
of sixty-two cases. Trans Am Ophthalmol Soc 1965;63:223–55.
85. Sohaib SA, Moseley I, Wright JE. Orbital rhabdomyosarcoma – the
radiological characteristics. Clin Radiol 1998;53(5):357–62.
Orbital masses: CT and MRI of common vascular lesions, benign 38386. Folpe AL, McKenney JK, Bridge JA, Weiss SW. Sclerosing
rhabdomyosarcoma in adults: report of four cases of a hyalinizing,
matrix-rich variant of rhabdomyosarcoma that may be confused with
osteosarcoma, chondrosarcoma, or angiosarcoma. Am J Surg
Pathol 2002;26(9):1175–83.
87. Mafee MF, Pai E, Philip B. Rhabdomyosarcoma of the orbit.
Evaluation with MR imaging and CT. Radiol Clin North America
1998;36(6):1215–27 xii.
88. Cota N, Chandna A, Abernethy LJ. Orbital abscess masquerading as
a rhabdomyosarcoma. J AAPOS: The Off Publ Am Assoc Pediatr
Ophthalmol Strab/Am Assoc Pediatr Ophthalmol Strab
2000;4(5):318–20.
89. Sepahdari AR, Aakalu VK, Kapur R, et al. MRI of orbital cellulitis and
orbital abscess: the role of diffusion-weighted imaging. AJR Am J
Roentgenol 2009;193(3):W244–50.
90. Koc O, Paksoy Y, Erayman I, Kivrak AS, Arbag H. Role of diffusion
weighted MR in the discrimination diagnosis of the cystic and/or
necrotic head and neck lesions. Eur J Radiol 2007;62(2):205–13.
91. Dutton JJ. Gliomas of the anterior visual pathway. Surv Ophthalmol
1994;38(5):427–52.
92. Thompson CR, Lessell S. Anterior visual pathway gliomas. Int
Ophthalmol Clin 1997;37(4):261–79.
93. Lertchavanakul A, Baimai C, Siwanuwatn R, Nuchprayoon I,
Phudhichareonrat S. Optic nerve glioma in infancy: a case report
of the youngest patient in Thailand. J Med Assoc Thailand =
Chotmaihet Thangphaet 2001;84(Suppl 1):S137–41.
94. Wulc AE, Bergin DJ, Barnes D, Scaravilli F, Wright JE, McDonald WI.
Orbital optic nerve glioma in adult life. Archiv Ophthalmol
1989;107(7):1013–6.95. Spencer W. Optic nerve. In: Spencer WH, editor. Ophthalmic
pathology, vol. 3. Philadelphia7: WB Saunders; 1996. p. 513–622.
96. Cirak B. Optic nerve glioma. J Neurosurg 2003;99(2 Suppl):246
Author reply 246.
97. Borit A, Richardson Jr EP. The biological and clinical behaviour of
pilocytic astrocytomas of the optic pathways. Brain: A J Neurol
1982;105(Pt 1):161–87.
98. Thiagalingam S, Flaherty M, Billson F, North K. Neurofibromatosis
type 1 and optic pathway gliomas: follow-up of 54 patients.
Ophthalmology 2004;111(3):568–77.
99. Parazzini C, Triulzi F, Bianchini E, et al. Spontaneous involution of
optic pathway lesions in neurofibromatosis type 1: serial contrast
MR evaluation. AJNR Am J Neuroradiol 1995;16(8):1711–8.
100. Parsa CF, Hoyt CS, Lesser RL, et al. Spontaneous regression of optic
gliomas: thirteen cases documented by serial neuroimaging. Archiv
Ophthalmol 2001;119(4):516–29.
101. Davis R. Juvenile pilocytic astrocytoma of the optic nerve: clinico-
pathologic study of sixty three cases. In: Jakobiec FA, editor. Ocular
and adnexal tumors. Birmingham7 Yanoff Aesculapius; 1978. p.
685–707.
102. Holman RE, Grimson BS, Drayer BP, Buckley EG, Brennan MW.
Magnetic resonance imaging of optic gliomas. Am J Ophthalmol
1985;100(4):596–601.
103. Weber AL, Klufas R, Pless M. Imaging evaluation of the optic nerve
and visual pathway including cranial nerves affecting the visual
pathway. Neuroimag Clin North America 1996;6(1):143–77.
